Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression.

Biomater Sci 2017 Aug;5(9):1898-1909

Chemical Biology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India.

The folate receptor (FR) is a well-validated and common target for cancer due to its high over-expression in many different cancer cells. Herein, we developed a new FR-targeting ligand (FA8) by conjugating folic acid and a cationic lipid. Owing to its favorable structural property FA8 as a ligand could be accommodated at an unusually higher molar ratio for a ligand-targeted liposome. We then encapsulated a drug-like molecule, bis-arylidene oxindole (NME2), in the targeted liposome. The resulting formulation induced potent caspase-8 up-regulation even in FR-moderately expressing melanoma cells. The NME2-associated non-targeted liposome (i.e., without FA8) or pristine NME2 could not up-regulate caspase-8. Caspase-8, an important apoptotic protein involved in the extrinsic pathway of apoptosis-signalling and inhibition of acquired drug resistance, was induced in cancer cells due to the combination treatment of liposomally associated FA8 and NME2 through the activation and subsequent cleavage of RIP-1. Consistently, in a melanoma tumor model too wherein FR is moderately expressed, significant tumour regression was obtained with this liposomal combination of FA8 and NME2. In conclusion, we demonstrate the development of a new FR-targeting ligand molecule whose higher level of inclusion (>10 mol%) in the liposomal formulation altered the mode of anticancer action of the encapsulated drug, thereby indicating a new therapeutic possibility involving FR targeted cancer treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c7bm00405bDOI Listing
August 2017
42 Reads

Publication Analysis

Top Keywords

fr-targeting ligand
8
bis-arylidene oxindole
8
fa8 nme2
8
melanoma tumor
8
cancer cells
8
fa8
5
nme2-associated non-targeted
4
non-targeted liposome
4
expressing melanoma
4
cells nme2-associated
4
melanoma cells
4
fr-moderately expressing
4
fa8 pristine
4
up-regulate caspase-8
4
caspase-8 caspase-8
4
molecule higher
4
nme2 up-regulate
4
pristine nme2
4
higher level
4
level inclusion
4

References

(Supplied by CrossRef)

Chen et al.
Nature 2013

Kelemen et al.
Int. J. Cancer 2006

Choi et al.
J. Nutr. 2000

Blount et al.
Proc. Natl. Acad. Sci. U. S. A. 1997

Stern et al.
Cancer Epidemiol. Biomarkers Prev. 2000

Strathdee et al.
Am. J. Pathol. 2001

Toffoli et al.
Int. J. Cancer 1998

Crane et al.
Cell. Oncol. 2012

Suh et al.
J. Gynecol. Oncol. 2012

Sudimack et al.
Adv. Drug Delivery Rev. 2000

Leamon et al.
Proc. Natl. Acad. Sci. U. S. A. 1991

Similar Publications